Short-form Ron kinase as a novel therapeutic target in ovarian cancer.

被引：0
|
作者：
Bieniasz, Magdalena [1 ]
Welm, Alana L. [1 ]
机构：
[1] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷
关键词：
D O I：
10.1158/1557-3265.OVCA15-A20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A20
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DNA methylation as a therapeutic target in ovarian cancer.
    Strathdee, G
    Appleton, K
    Plumb, J
    Brown, R
    CLINICAL CANCER RESEARCH, 2000, 6 : 4505S - 4505S
  • [2] Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
    Ulm, Michael A.
    Redfern, Tiffany M.
    Wilson, Ben R.
    Ponnusamy, Suriyan
    Asemota, Sarah
    Blackburn, Patrick W.
    Wang, Yinan
    ElNaggar, Adam C.
    Narayanan, Ramesh
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 15
  • [3] β-catenin as a TIC therapeutic target in epithelial ovarian cancer.
    Nagaraj, Anil Belur
    Joseph, Peronne
    Kovalenko, Olga
    Singh, Sareena
    Armstrong, Amy
    DiFeo, Analisa
    CLINICAL CANCER RESEARCH, 2016, 22
  • [4] Rac1 as a therapeutic target in ovarian cancer.
    Rivera, Melanie
    Grimes, Martha M.
    Dominguez, Dayna
    Kenney, S. Ray
    Guo, Yuna
    Romero, Elsa
    Brayer, Kathryn J.
    Guo, Yan
    Ness, Scott A.
    Adams, Sarah F.
    Muller, Carolyn
    Hudson, Laurie G.
    Wandinger-Ness, Angela
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 116 - 116
  • [5] RON Kinase Is a Novel Therapeutic Target for Philadelphia-Negative Myeloproliferative Neoplasms
    Gurska, Lindsay Meg
    Okabe, Rachel
    Tong, Meng Maxine
    Choi, Daniel
    Ames, Kristina
    Glushakow-Smith, Shira
    Montoya, Allison
    Tein, Ellen
    Cheng, Haiying
    Goel, Swati
    Halmos, Balazs
    Gritsman, Kira
    BLOOD, 2021, 138
  • [6] Ron receptor tyrosine kinase signaling as a therapeutic target
    Benight, Nancy M.
    Waltz, Susan E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (09) : 921 - 931
  • [7] Inhibition of short-form ron eliminates breast cancer metastases through an immune-mediated mechanism
    Lai, Shu-Chin Alicia
    Gundlapalli, Harika
    Ekiz, Huseyin A.
    Welm, Alana L.
    CANCER RESEARCH, 2021, 81 (04)
  • [8] Rac1 as a driver and therapeutic target in ovarian cancer.
    Rivera, Melanie
    Grimes, Martha M.
    Hudson, Laurie G.
    Wandinger-Ness, Angela
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer
    Wu, Zheng
    Zhang, Zhe
    Ge, Xiaoxiao
    Lin, Ying
    Dai, Congqi
    Chang, Jinjia
    Liu, Xinyang
    Geng, Ruixuan
    Wang, Chenchen
    Chen, Huan
    Sun, Menghong
    Guo, Weijian
    Li, Jin
    ONCOTARGET, 2015, 6 (38) : 40519 - 40534
  • [10] ER stress: A novel therapeutic target in pancreatic cancer.
    Nawrocki, ST
    Carew, JS
    Pino, MS
    Highshaw, RA
    Andtbacka, RH
    Dunner, K
    Bornmann, W
    Huang, P
    Boise, LH
    Abbruzzese, JL
    McConkey, DJ
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9038S - 9038S
12345